November 20th, 2024 - 

LEVEL OF NOTIFICATION:                 Consumer

SUPPLIER:                                              Endo - # 37089, 37096

Event Description:

Endo is voluntarily recalling the above items/lots due to the complaint that a limited number of distributed packs have the incorrect strength product cartons as a result of a packaging error. This recall is to the Consumer level. Affected product started shipping April 1, 2024.

Consumer Information:

Consumers in possession of any unused lots please discontinue use of the product.

September 24th, 2024 - 

LEVEL OF NOTIFICATION:                 Consumer

SUPPLIER:                                              Sandoz - # 17529, 34249

Event Description:

Sandoz is issuing a Dear Health Care Provider Letter related to an inconsistency in the labeling of Enoxaparin syringes. The carton and blister labeling inaccurately reads that the graduation lines on the syringe represent intervals of .02 ML. The label on the syringe accurately states that the smaller graduation lines on the syringes represent .1 ML intervals. The above items/lots is to the Consumer level.

Consumer Information:

Customers may continue to take the medication as prescribed. This is for information purposes only and no action is needed. If you have questions, contact Sedgwick at 855-215-5827. Please report and adverse reactions by calling Sandoz at 800-525-8747 or you can report to the FDA at www.fda.gov/medwatch/report.htm.

September 24th, 2024 - 

LEVEL OF NOTIFICATION: Consumer

SUPPLIER:                      Sandoz - #17529

Event Description:

Sandoz is issuing a Dear Health Care Provider Letter related to an inconsistency in the labeling of Enoxaparin syringes. The carton and blister labeling inaccurately reads that the graduation lines on the syringe represent intervals of .02 ML. The label on the syringe accurately states that the smaller graduation lines on the syringes represent .1 ML intervals. The above items/lots is to the Consumer level.

Consumer Information:

Customers may continue to take the medication as prescribed. This is for information purposes only and no action is needed. If you have questions, contact Sedgwick at 855-215-5827. Please report and adverse reactions by calling Sandoz at 800-525-8747 or you can report to the FDA at www.fda.gov/medwatch/report.htm.

LEVEL OF NOTIFICATION:                 Consumer

SUPPLIER:                                              BioPharma - # 03544

Event Description:

BionPharma is voluntarily recalling the above item/lot due to Cohnella bacteria being found. This recall is to the Consumer level. Affected product started shipping December 21, 2023.

Consumer Information:

Consumers that have products which are being recalled should discard and contact their doctor. 

August 23th, 2024 - 

SUPPLIER:                                              Hikma - # 49158

Event Description:

Hikma is voluntarily recalling the above item/lot due to the report of a unit of Acetaminophen that had the correct NDC and lot information on the overwrap appears to have contained withing it a bag of Dexmedetomidine HCL Injection 400mcg/100ml. McKesson does not carry NDC 0143-9386-01 which is the individual bag (pouch). This recall is to the Consumer level. Affected product started shipping June 7, 2024.

Consumer Information:

If you have the affected lot number(s), please complete and return the response form to Inmar via fax at 817-868-5362 or email to HikmaEvent@Inmar.com. Upon receipt, Inmar will issue a Returns Kit. Please complete the response form even if you do not have product. For information regarding the recall process call Hikma at 1-800-631-2174 or email at usrecall@hikma.com.

July 29th, 2024 - 

SUPPLIER:                      B. Braun - # 6291

Event Description:

B. Braun is voluntarily recalling the above item/lots due to the potential for particulate matter and leakage.  This recall is to the Consumer level. Affected product started shipping February 1, 2024.

Consumer Information:

Contact your healthcare provider for any medical related questions.

July 8th, 2024 -

Event Description:

Endo is voluntarily recalling the above item/lot due to a limited number of distributed packs that have the incorrect strength on the cartons. Clonazepam Orally Disintegrating .25mg lot 5501473601 may have been packaged in a carton labelled as Clonazepam Orally Disintegrating tablets .125mg. This recall is to the Consumer level. Affected product started shipping April 1, 2024

Consumer Information:

Notification to customers may include a copy of the Response form. Please instruct you customers to follow steps 1 and 2. Complete and return the response form to Inmar via fax at 817-868-5362 or email to rxrecalls@inmar.com. Upon receipt, Inmar will issue a Returns Kit. Please complete the response form even if you do not have product. If you have affected product and need a response form, contact Inmar at 877-890-0765. Customers need to return product directly to the Mfg or Mfg designee.

JUNE 27TH, 2024 - 

Event Description:

Glenmark is voluntarily recalling the above items/lots due to the out of specification results observed in dissolution test (By AAS) during long term stability. This recall is to the Consumer level. Affected product started shipping August 1, 2022.

Consumer Information:

Prior to returning the recalled medication, you should consult with your pharmacist, who can advise you about replacement or reimbursement for your medication. Since there might be a potential for adverse health consequences associated with stopping the medication, you should also consult with your healthcare provider or physician. Once you have a new prescription, please return any remaining product that is subject to this recall to Inmar Rx Solutions. Please call Inmar at 877-883-9273 to request a Return Authorization and to discuss and reimbursement questions. Once you receive the return label and kit, return affected product to Inmar Rx Solutions at 3845 Grand Lakes Way, Grand Prairie, TX 75050. Please complete the response form and return via fax to 817-868-5362 or email to Rxrecalls@inmar.com.

June 10th, 2024 -